Dr. Aldridge’s laboratory works on developing drugs for tuberculosis which kills ~2 million people every year. Her research focuses on designing optimized therapies for TB using cell biology and engineering approaches. Her lab is a multidisciplinary research team, integrating quantitative measurement with computational modeling and analysis to create intuitive descriptions of complex cell biology. She has now started to apply her TB platforms to developing new drugs for the treatment and prevention of Lyme disease.  Using a multi-omic approach called DECIPHAER, she collaborates with Dr. Maha Farhat and Dr. Linden Hu understanding the mechanisms of actions for new antibiotics against B. burgdorferi that are identified using machine learning approaches.  

Dr. Aldridge enjoys cooking and attending fife and drum performances in her spare time.